982641

Wuhan Biocause Pharmaceutical Development Co., Ltd. — FEI 3004202226

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 22, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wuhan (China)